- Home
- CNTA vs ETY Comparison
CNTA vs ETY Comparison
Compare CNTA & ETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- ETY
- Stock Information
- Founded
- CNTA 2020
- ETY 2006
- Country
- CNTA United Kingdom
- ETY United States
- Employees
- CNTA N/A
- ETY N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- ETY Finance Companies
- Sector
- CNTA Health Care
- ETY Finance
- Exchange
- CNTA Nasdaq
- ETY Nasdaq
- Market Cap
- CNTA 1.8B
- ETY 2.1B
- IPO Year
- CNTA 2021
- ETY N/A
- Fundamental
- Price
- CNTA $12.30
- ETY $14.26
- Analyst Decision
- CNTA Strong Buy
- ETY
- Analyst Count
- CNTA 10
- ETY 0
- Target Price
- CNTA $26.11
- ETY N/A
- AVG Volume (30 Days)
- CNTA 617.5K
- ETY 247.3K
- Earning Date
- CNTA 05-20-2025
- ETY 01-01-0001
- Dividend Yield
- CNTA N/A
- ETY 7.21%
- EPS Growth
- CNTA N/A
- ETY N/A
- EPS
- CNTA N/A
- ETY N/A
- Revenue
- CNTA N/A
- ETY N/A
- Revenue This Year
- CNTA N/A
- ETY N/A
- Revenue Next Year
- CNTA N/A
- ETY N/A
- P/E Ratio
- CNTA N/A
- ETY N/A
- Revenue Growth
- CNTA N/A
- ETY N/A
- 52 Week Low
- CNTA $7.75
- ETY $10.59
- 52 Week High
- CNTA $19.09
- ETY $13.46
- Technical
- Relative Strength Index (RSI)
- CNTA 40.97
- ETY 58.79
- Support Level
- CNTA $11.88
- ETY $13.99
- Resistance Level
- CNTA $14.39
- ETY $14.37
- Average True Range (ATR)
- CNTA 0.79
- ETY 0.25
- MACD
- CNTA -0.00
- ETY 0.12
- Stochastic Oscillator
- CNTA 18.68
- ETY 92.99
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.